ArticleJournal of gastroenterology2019

Cost-utility analysis of a 'vonoprazan-first' strategy versus 'esomeprazole- or rabeprazole-first' strategy in GERD.

Yuta Yokoya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.